A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular haemorrhage

Ye L ;
Wu R ;
Li J ;
Hu Z

Cataract department, Eye Hospital of Wenzhou Medical University, Wenzhou, China. Fundus Disease Center, Eye Hospital of Wenzhou Medical University, Wenzhou, China. Fundus Disease Center, Eye Hospital of Wenzhou Medical University, Wenzhou, China - zhixianghucn@163.com.

Minerva medica. 2022

Full text from:

Minerva Medica

Study details

Study Design : Randomised Controlled Trial

Language : eng

Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular haemorrhage

Other resources